Early events in human cytomegalovirus infection

Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis

Volumn , Issue , 2007, Pages 231-240

  Compton, Teresa ^a   Feire, Adam ^b  

^a NIBRI (Novartis)   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 52649100505     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545313.017     Document Type: Chapter

References (101)

1. Akira, S. (2001). Toll-like receptors and innate immunity. Adv. Immunol., 78, 1-56.
2. Albrecht, T. and Weller, T. H. (1980). Heterogeneous morpho-logic features of plaques induced by ?ve strains of human cytomegalovirus. Am. J. Clin. Pathol., 73(5), 648-654.
3. Albrecht, T., Speelman, D. J., and Steinsland, O. S. (1983). Similari-ties between cytomegalovirus-induced cell rounding and con-traction of smooth muscle cells. Life Sci., 32(19), 2273-2278.
4. Baldwin, B. R., Zhang, C., and Keay, S. (2000). Cloning and epi-tope mapping of a functional partial fusion receptor for human cytomegalovirus gH. J. Gen. Virol., 81, 27-35.
5. Beersma, M. F., Wertheim, van, D. P., and Feltkamp, T. E. (1990). The in?uence of HLA-B27 on the infectivity of cytomegalovirus for mouse ?broblasts. Scand. J. Rheumatol. Suppl., 87(102), 102-103.
6. Beersma, M. F., Wertheim, van, D. P., Geelen, J. L., and Feltkamp, T. E. (1991). Expression of HLA class I heavy chains and beta 2-microglobulindoesnotaffecthumancytomegalovirusinfec-tivity. J. Gen. Virol., 72, 2757-2764
7. Berman, A. E. and Kozlova, N. I. (2000). Integrins: Structure and functions. Membr. Cell Biol., 13(2), 207-244.
8. Berman, A. E., Kozlova, N. I., and Morozevich, G. E. (2003). Integrins: Structure and signaling. Biochemistry (Mosc)., 68(12), 1284-1299.
9. Boehme, K. and Compton, T. (2004). Innate sensing of viruses by toll-like receptors. J. Virol., 78, 7867-7873.
10. Boehme, K. W., Singh, J., Perry, S. T., and Compton, T. (2004). Human cytomegalovirus elicits a coordinated cellular antivi-ral response via envelope glycoprotein B. J. Virol., 78(3), 1202-1211.
11. Bold, S., Ohlin, M., Garten, W., and Radsak, K. (1996). Structural domains involved in human cytomegalovirus glycoprotein B-mediated cell-cell fusion. J. Gen. Virol., 77, 2297-2302.
12. Boldogh, I., AbuBakar, S., and Albrecht, T. (1990). Activation of proto-oncogenes: An immediate early event in human cytomegalovirus infection. Science, 247, 561-564.
13. Boldogh, I., AbuBakar, S., Deng, C. Z., and Albrecht, T. (1991a). Tran-scriptional activation of cellular oncogenes fos, jun, and myc by human cytomegalovirus. J. Virol., 65(3), 1568-1571.
14. Boldogh, I., AbuBakar, S., Millinoff, D., Deng, C. Z., and Albrecht, T. (1991b). Cellular oncogene activation by human cytomegalovirus. Lack of correlation with virus infectivity and immediate early gene expression. Arch. Virol., 118, 163-177.
15. Borst, E. M., Hahn, G., Koszinowski, U. H., and Messerle, M. (1999). Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial arti?cial chromosome in Escherichia coli: A new approach for construction of HCMV mutants. J. Virol., 73(10), 8320-8329.
16. Boyle, K. A. and Compton, T. (1998). Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B. J. Virol., 72, 1826-1833.
17. Boyle, K. A., Pietropaolo, R. L., and Compton, T. (1999). Engage-ment of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway. Mol. Cell Biol. 19, 3607-3713.
18. Britt, W. J. (1984). Neutralizing antibodies detect a disul?de-linked glycoprotein complex within the envelope of human cytomegalovirus. Virology, 135, 369-378.
19. Britt, W. J. and Auger, D. (1986). Human cytomegalovirus virion-associated protein with kinase activity. J. Virol., 59(1), 185-188.
20. Britt, W. J., Jarvis, M., Seo, J. Y., Drummond, D., and Nelson, J. (2004). Rapid genetic engineering of human cytomegalovirus by using a lambda phage linear recombination system: DemonstratIon that pp28 (UL99) is essential for production of infectious virus. J. Virol., 78(1), 539-543.
21. Browne, E. P., Wing, B., Coleman, D., and Shenk, T. (2001). Altered cellular mRNA levels in human cytomegalovirus-infected ?broblasts: Viral block to the accumulation of antiviral mRNAs. J. Virol., 75(24), 12319-12330.
22. Browne, H., Smith, G., Beck, S., and Minson, T. (1990). A com-plex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin. Nature, 347(6295), 770-772.
23. Carlson, C., Britt, W. J., and Compton, T. (1997). Expression, puri?cation and characterization of a soluble form of human cytomegalovirus glycoprotein B. Virology, 239, 198-205.
24. Cary, L. A., Han, D. C., and Guan, J. L. (1999). Integrin-mediated signal transduction pathways. Histol. Histopathol., 14(3), 1001-1009.
25. Compton, T., Nowlin, D. M., and Cooper, N. R. (1993). Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology, 193(2), 834-841.
26. Compton, T., Kurt-Jones, E. A., Boehme, K. W. et al. (2003). Human cytomegalovirus activates in?ammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol., 77(8), 4588-4596.
27. Conti, C., Cirone, M., Sgro, R., Altieri, F., Zompetta, C., and Fag-gioni, A. (2000). Early interactions of human herpesvirus 6 with lymphoid cells: Role of membrane protein components and glycosaminoglycans in virus binding. J. Med. Virol., 62(4), 487-497.
28. Dunn, W., Chou, C., Li, H., Hai, R., Patterson, D., Stolc, V., Zhu, H., and Liu, F. (2003). Functional pro?ling of a human cytomegalovirus genome. Proc. Natl Acad. Sci. USA, 100(24), 14223-14228.
29. Eto, K., Huet, C., Tarui, T. et al. (2002). Functional classi?cation of ADAMs based on a conserved motif for binding to integrin alpha 9beta 1: Implications for sperm-egg binding and other cell interactions. J. Biol. Chem., 277(20), 17804-17810.
30. Fairley, J. A., Baillie, J., Bain, M., and Sinclair, J. H. (2002). Human cytomegalovirus infection inhibits epidermal growth factor (EGF) signalling by targeting EGF receptors. J. Gen. Virol., 83(11), 2803-2810.
31. Feire, A. L., Koss, H., and Compton, T. (2004). Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc. Natl Acad. Sci. USA, 101(43), 15470-15475.
32. Fortunato, E. A., McElroy, A. K., Sanchez, I., and Spector, D. H.(2000). Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. Trends Microbiol., 8(3), 111-119.
33. Giugni, T. D., Soderberg, C., Ham, D. J. et al. (1996). Neutralization of human cytomegalovirus by human CD13-speci?c antibodies. J. Infect. Dis., 173(5), 1062-1071.
34. Gredmark, S., Britt, W. B., Xie, X., Lindbom, L., and Soderberg-Naucler, C. (2004). Human cytomegalovirus induces inhi-bition of macrophage differentiation by binding to human aminopeptidase N/CD13. J. Immunol., 173(8), 4897-4907.
35. Gretch, D. R., Kari, B., Rasmussen, L., Gehrz, R. C., and Stinski, M. F. (1988). Identi?cation and characterization of three distinct families of glycoprotein complexes in the envelopes of human cytomegalovirus. J. Virol., 62(3), 875-881.
36. Grundy, J. E., McKeating, J. A., and Grif?ths, P. D. (1987a). Cytomegalovirus strain AD169 binds beta 2 microglobulin in vitro after release from cells. J. Gen. Virol., 68, 777-784.
37. Grundy, J. E., McKeating, J. A., Ward, P. J., Sanderson, A. R., and Grif-?ths, P. D. (1987b). Beta 2 microglobulin enhances the infec-tivity of cytomegalovirus and when bound to the virus enables class I HLA molecules to be used as a virus receptor. J. Gen. Virol., 68, 793-803.
38. Grundy, J. E., McKeating, J. A., Sanderson, A. R., and Grif?ths, P. D. (1988). Cytomegalovirus and beta 2 microglobulin in urine specimens. Reciprocal interference in their detection is responsible for artifactually high levels of urinary beta 2 microglobulin in infected transplant recipients. Transplanta-tion, 45(6), 1075-1079.
39. Haynes, L. M., Moore, D. D., Kurt-Jones, E. A., Finberg, R. W., Ander-son, L. J., and Tripp, R. A. (2001). Involvement of toll-like recep-tor 4 in innate immunity to respiratory syncytial virus. J. Virol., 75(22), 10730-10737.
40. Hobom, U., Brune, W., Messerle, M., Hahn., G., and Koszinowski, U. (2000). Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: Mutational analy-sis of human cytomegalovirus envelope glycoprotein genes. J. Virol., 74(17), 7720-7729.
41. Huber, M. T. and Compton, T. (1997). Characterization of a novel third member of the human cytomegalovirus glycoprotein H-glycoprotein L complex. J. Virol., 71, 5391-5398.
42. Huber, M. T. and Compton, T. (1998). The human cytomegalovirus UL74 geneencodesthethirdcomponentoftheglycoprotein H-glycoprotein L-containing envelope complex. J. Virol., 72(10), 8191-8197.
43. Ibanez, C. E., Schrier, R., Ghazal, P., Wiley, C., and Nelson, J. A. (1991). Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol., 65(12), 6581-6588.
44. Ihara, S., Saito, S., and Watanabe, Y. (1982). Suppression of ?bronectin synthesis by an early function(s) of human cytomegalovirus. J. Gen. Virol., 59(2), 409-413.
45. Johnson, R. A., Wang, X., Ma, X. L., Huong, S. M., and Huang, E. S. (2001) Human cytomegalovirus upregulates the phos-phatidylinositol 3-kinase (PI3-K) pathway: Inhibition of PI3-K activity inhibits replication and virus-induced signalling. J. Virol., 75, 6022-6032.
46. Jones, P. L., Crack, J., and Rabinovitch, M. (1997). Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epider-mal growth factor receptor phosphorylation and growth. J. Cell Biol., 139(1), 279-293.
47. Kari, B. and Gehrz, R. (1993). Structure, composition and heparin binding properties of a human cytomegalovirus glycoprotein complex designated gC-II. J. Gen. Virol., 74(2), 255-264.
48. Keay, S. and Baldwin, B. (1991). Anti-idiotype antibodies that mimic gp86 of human cytomegalovirus inhibit viral fusion but not attachment. J. Virol., 65(9), 5124-5128.
49. Keay, S. and Baldwin, B. (1992). The human ?broblast receptor for gp86 of human cytomegalovirus is a phosphorylated glycopro-tein. J. Virol., 66(8), 4834-4838.
50. Keay, S. and Baldwin, B. R. (1996). Evidence for the role of cell protein phosphorylation in human cytomegalovirus/host cell fusion. J. Gen. Virol., 77(10), 2597-2604.
51. Keay, S., Rasmussen, L., and Merigan, T. C. (1988). Syngeneic mono-clonal anti-idiotype antibodies that bear the internal image of a human cytomegalovirus neutralization epitope. J. Immunol., 140(3), 944-948.
52. Keay, S., Merigan, T. C., and Rasmussen, L. (1989). Identi?cation of cell surface receptors for the 86-kilodalton glycoprotein of human cytomegalovirus. Proc. Natl Acad. Sci. USA, 86(24), 10100-10103.
53. Keay, S., Baldwin, B. R., Smith, M. W., Wasserman, S. S., and Gold-man, W. F. (1995). Increases in [Ca2+ ]i mediated by the 92.5-kDa putative cell membrane receptor for HCMV gp86. Am. J. Physiol., 269(1 Pt 1), C11-21.
54. Kowalik, T. F., Wing, B., Haskill, J. S., Azizkhan, J. C., Baldwin, A. S., Jr., and Huang, E. S. (1993). Multiple mechanisms are impli-cated in the regulation of NF-kappa B activity during human cytomegalovirus infection. Proc. Natl Acad. Sci. USA, 90(3), 1107-1111.
55. Kurt-Jones, E. A., Popova, L., Kwinn, L. et al. (2000). Pattern recogni-tion receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol., 1(5), 398-401.
56. Larsson, S., Soderberg-Naucler, C., Wang, F. Z., and Moller, E. (1998). Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion, 38(3), 271-278.
57. Li, L., Nelson, J. A., and Britt, W. J. (1997). Glycoprotein H-related complexes of human cytomegalovirus: Identi?cation of a third protein in the gCIII complex. J. Virol., 71, 3090-3097.
58. Lopper, M. and Compton, T. (2004). Coiled-coli domains in glycoproteins B and H are involved in human cytomegalovirus membrane fusion. J. Virol., 78(15), 8333-8341.
59. Lusso, P., Secchiero, P., Crowley, R. W., Garzino-Demo, A., Berne-man, Z. N., and Gallo, R. C. (1994). CD4 is a critical component of the receptor for human herpesvirus 7: Interference with human immunode?ciency virus. Proc. Natl Acad. Sci. USA, 91(9), 3872-3876.
60. Mach, M., Kropff, B., Dal Monte, P., and Britt, W. (2000). Com-plex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73). J. Virol., 74(24), 11881-11892.
61. McKeating, J. A., Grundy, J. E., Varghese, Z., and Grif?ths, P. D. (1986). Detection of cytomegalovirus by ELISA in urine sam-ples is inhibited by beta 2 microglobulin. J. Med. Virol., 18(4), 341-348.
62. McKeating, J. A., Grif?ths, P. D., and Grundy, J. E. (1987). Cytomegalovirus in urine specimens has host beta 2 microglobulin bound to the viral envelope: A mechanism of evading the host immune response? J. Gen. Virol., 68, 785-792.
63. Miyamoto, S., Teramoto, H., Gutkind, J. S., and Yamada, K. M. (1996). Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: Roles of integrin aggregation and occupancy of receptors. J. Cell Biol., 135(6 Pt 1), 1633-1642
64. Moro, L., Venturino, M., Bozzo, C. et al. (1998). Integrins induce activation of EGF receptor: Role in MAP kinase induction and adhesion-dependent cell survival. EMBOJ., 17(22), 6622-6632.
65. Myerson, D., Hackman, R. C., Nelson, J. A., Ward, D. C., and McDougall, J. K. (1984). Widespread presence of histologically occult cytomegalovirus. Hum. Pathol., 15(5), 430-439.
66. Netterwald, J. R., Jones, T. R., Britt, W. J., Yang, S. J., McCrone, I. P., and Zhu, H. (2004). Postattachment events associated with viral entry are necessary for induction of interferon-stimulated genes by human cytomegalovirus. J. Virol., 78(12), 6688-6691.
67. Nowlin, D. M., Cooper, N. R., and Compton, T. (1991). Expression of a human cytomegalovirus receptor correlates with infectibility of cells. J. Virol., 65(6), 3114-3121
68. Ogawa, T., Asai, Y., Hashimoto, M., and Uchida, H. (2002). Bacterial ?mbriae activate human peripheral blood monocytes utiliz-ing TLR2, CD14 and CD11a/CD18 as cellular receptors. Eur. J. Immunol., 32(9), 2543-2550.
69. Pietropaolo, R. and Compton, T. (1997). Direct interaction between human cytomegalovirus glycoprotein B and cellular annexin II. J. Virol., 71, 9803-9807.
70. Pietropaolo, R. and Compton, T. (1999). Interference with annexin II has no effect on entry of human cytomegalovirus into ?brob-last cells. J. Gen. Virol., 80(7), 1807-1816.
71. Pleskoff, O., Treboute, C., Brelot, A., Heveker, N., Seman, M., and Ali-zon, M. (1997). Identi?cation of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Sci-ence, 276(5320), 1874-1878.
72. Pleskoff, O., Treboute, C., and Alizon, M. (1998). The cytomegalovirus-encoded chemokine receptor US28 can enhance cell-cell fusion mediated by different viral proteins. J. Virol., 72(8), 6389-6397.
73. Polic, B., Jonjic, S., Pavic, I. et al. (1996). Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo. J. Gen. Virol., 77(2), 217-225.
74. Rassa, J. C., Meyers, J. L., Zhang, Y., Kudaravalli, R., and Ross, S. R. (2002). Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc. Natl Acad. Sci. USA, 99(4), 2281-2286.
75. Raynor, C. M., Wright, J. F., Waisman, D. M., and Pryzdial, E. L.(1999). Annexin II enhances cytomegalovirus binding and fusion to phospholipid membranes. Biochemistry, 38(16), 5089-5095.
76. Santoro, F., Kennedy, P. E., Locatelli, G., Malnati, M. S., Berger, E. A., and Lusso, P. (1999). CD46 is a cellular receptor for human herpesvirus 6. Cell, 99(7), 817-827.
77. Simmen, K. A., Singh, J., Luukkonen, B. G., Lopper, M., Bittner, A., Miller, N. E., Jackson, M. R., Compton, T., and Fruh, K. (2001). Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc. Natl Acad. Sci. USA, 98(13), 7140-7145.
78. Sinzger, C., Kahl, M., Laib, K. et al. (2000). Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on ef?cient translocation to the nucleus. J. Gen. Virol., 81(12), 3021-3035.
79. Soderberg, C., Giugni, T. D., Zaia, J. A., Larsson, S., Wahlberg, J. M., and Moller, E. (1993a). CD13 (human aminopeptidase-N) mediates human cytomegalovirus infection. J. Virol., 67(11), 6576-6585.
80. Soderberg, C., Larsson, S., Bergstedtlindqvist, S., and Moller, E. (1993b). De?nition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J. Virol., 67(6), 3166-3175.
81. Spear, P. G. and Longnecker, R. (2003). Herpesvirus entry: An update. J. Virol., 77(19), 10179-10185.
82. Stannard, L. M. (1989). Beta 2 microglobulin binds to the tegument of cytomegalovirus: An immunogold study. J. Gen. Virol., 70, 2179-2184.
83. Stewart, P. L., Dermody, T. S., and Nemerow, G. R. (2003). Structural basis for nonenveloped virus entry. Adv. Protein Chem., 64, 455-491.
84. Stone, A. L., Kroeger, M., and Sang, Q. X. (1999). Structure-function analysis of the ADAM family of disintegrin-like and metalloproteinase-containing proteins (review). J. Protein Chem., 18(4), 447-465.
85. Taylor, H. P. and Cooper, N. R. (1990). The human cytomegalovirus receptor on ?broblasts is a 30-kilodalton membrane protein. J. Virol., 64(6), 2484-2490.
86. Trianta?lou, M., Miyake, K., Golenbock, D. T., and Trianta?lou, K. (2002). Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell Sci., 115(12), 2603-2611.
87. Tugizov, S., Navarro, D., Paz, P., Wang, Y. L., Qadri, I., and Pereira, L. (1994). Function of human cytomegalovirus glycoprotein B: Syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies. Virology, 201(2), 263-276.
88. Utz, U., Britt, W., Vugler, L., and Mach, M. (1989). Identi?cation of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus. J. Virol., 63, 1995-2001.
89. Wang, X., Huong, S. M., Chiu, M. L., Raab-Traub, N., and Huang, E. S. (2003). Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature, 424(6947), 456-461.
90. Warren, A. P., Owens, C. N., Borysiewicz, L. K., and Patel, K. (1994). Down-regulation of integrin alpha 1/beta 1 expression and association with cell rounding in human cytomegalovirus-infected ?broblasts. J. Gen. Virol., 75(12), 3319-3325.
91. White, J. M. (2003). ADAMs: Modulators of cell-cell and cell-matrix interactions. Curr. Opin. Cell Biol., 15(5), 598-606.
92. Wolfsberg, T. G., Primakoff, P., Myles, D. G., and White, J. M. (1995). ADAM, a novel family of membrane proteins contain-ing a disintegrin and metalloprotease domain: Multipotential functions in cell-cell and cell-matrix interactions. J. Cell Biol., 131(2), 275-278.
93. Wright, R., Kurosky, A., and Wasi, S. (1993). Annexin II associated with human cytomegalovirus particles: Possible implications for cell infectivity. FASEB J., 7, A1301.
94. Wright, J. F., Kurosky, A., and Wasi, S. (1994). An endothelial cell-surface form of annexin II binds human cytomegalovirus. Biochem. Biophys. Res. Commun., 198(3), 983-989.
95. Wright, J. F., Kurosky, A., Pryzdial, E. L., and Wasi, S. (1995). Host cellular annexin II is associated with cytomegalovirus particles isolated from cultured human ?broblasts. J. Virol., 69, 4784-4791.
96. Wu, Q. H., Trymbulak, W., Tatake, R. J., Forman, S. J., Zeff, R. A., and Shanley, J. D. (1994). Replication of human cytomegalovirus in cells de?cient in beta(2)-microglobulin gene expression. J. Gen. Virol., 75(10), 2755-2759.
97. Yu, D., Smith, G. A., Enquist, L. W., and Shenk, T. (2002). Con-struction of a self-excisable bacterial arti?cial chromosome containing the human cytomegalovirus genome and muta-genesis of the diploid TRL/IRL13 gene. J. Virol., 76(5), 2316-2328.
98. Yurochko, A. D. and Huang, E. S. (1999). Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression. J. Immunol., 162, 4806-4816.
99. Yurochko, A. D., Kowalik, T. F., Huong, S. M., and Huang, E. S. (1995). Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J. Virol., 69(9), 5391-5400.
100. Yurochko, A. D., Hwang, E. S., Rasmussen, L., Keay, S., Pereira, L., and Huang, E. S. (1997). The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid acti-vation of Sp1 and NF-kappaB during infection. J. Virol., 71, 5051-5059.
101. Zhu, H., Cong, J. P., Mamtora, G., Gingeras, T., and Shenk, T. (1998). Cellular gene expression altered by human cytomegalovirus: Global monitoring with oligonucleotide arrays. Proc. Natl Acad. Sci. USA, 95(24), 14470-14475.